COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics

AP Spihlman, N Gadi, SC Wu, VR Moulton - Frontiers in Immunology, 2020 - frontiersin.org
The SARS-CoV-2 novel coronavirus has caused the COVID-19 pandemic with over 35
million cases and over a million deaths worldwide as of early October 2020. The populations …

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

SE Sattui, JW Liew, ER Graef… - Expert Review of …, 2020 - Taylor & Francis
Introduction Several months into the COVID-19 pandemic, safe and effective treatments
against this global health disaster have yet to be identified. Clinical research trials around …

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician …

M Gianfrancesco, KL Hyrich, S Al-Adely… - Annals of the …, 2020 - ard.bmj.com
Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly
understood. The aim was to examine demographic and clinical factors associated with …

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'

KM D'Silva, N Serling-Boyd, R Wallwork… - Annals of the …, 2020 - ard.bmj.com
Objective To investigate differences in manifestations and outcomes of coronavirus disease
2019 (COVID-19) infection between those with and without rheumatic disease. Methods We …

Determinants of COVID-19 disease severity in patients with underlying rheumatic disease

CS Santos, CM Morales, ED Álvarez, CÁ Castro… - Clinical …, 2020 - Springer
Background Over the month of April, Spain has become the European country with more
confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd. The community of …

The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web …

E Seyahi, BC Poyraz, N Sut, S Akdogan… - Rheumatology …, 2020 - Springer
We hypothesized that patients with rheumatic diseases (RD) would have increased
psychological distress during the COVID-19 outbreak; therefore, assessed their …

Case series of acute arthritis during COVID-19 admission

ML Peral-Garrido, I Calabuig… - Annals of the …, 2021 - ard.bmj.com
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
changed life significantly worldwide. Rheumatologists also had to get used to the new …

Antirheumatic disease therapies for the treatment of COVID‐19: a systematic review and meta‐analysis

M Putman, YPE Chock, H Tam, AHJ Kim… - Arthritis & …, 2021 - Wiley Online Library
Objective Antirheumatic disease therapies have been used to treat coronavirus disease
2019 (COVID‐19) and its complications. We conducted a systematic review and meta …

The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study

N Ziadé, I Hmamouchi, L El Kibbi, N Abdulateef… - Clinical …, 2020 - Springer
Objective To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on
rheumatology practice. Method A cross-sectional web survey was designed by the members …

Impact of the COVID‐19 pandemic on patients with chronic rheumatic diseases: a study in 15 Arab countries

N Ziade, L El Kibbi, I Hmamouchi… - … journal of rheumatic …, 2020 - Wiley Online Library
Aim To evaluate the impact of the coronavirus disease 2019 pandemic (COVID‐19) on the
access to rheumatology care for patients with chronic rheumatic diseases (CRD) in the Arab …